Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Australian seagulls found to carry antibiotic resistant bacteria
Silver gulls carry bacteria that are resistant to the commonly used antimicrobial drugs, cephalosporins and fluoroquinolones.
Birds earmarked as potential reservoirs for human disease

Seagulls across Australia carry antibiotic resistant bacteria that cause serious infections in humans, according to new research.

Scientists at Murdoch University, Perth, found that 20 per cent of silver gulls carry bacteria that cause infections such as E.coli, urinary tract infections and sepsis. Study leader Dr Sam Abraham said the problem was prevalent across Australia.

“Seagulls act as ecological sponges (bio-accumulators) and we have earmarked them as a potential reservoir for agents that may cause human disease,” he explained.

The study revealed that silver gulls carry bacteria that are resistant to the commonly used antimicrobial drugs, cephalosporins and fluoroquinolones. It also found resistance to carbapanem drugs - a class of antibiotics often used for severe infections - in birds from New South Wales and Victoria.

The researchers also found evidence of a seagull in Western Australia carrying resistance to the ‘last resort’ antibiotic, colistin. Study author Dr Mark O’Dea said it was the first time resistance to this drug has been recorded in an Australian wild animal.

“Our results have raised the concern that seagulls could be acquiring this pathogen through their opportunistic feeding habits where they scavenge from leftover human waste and may then be subsequently spreading these resistant bacteria over vast distances,” he said.

“Management of this issue will require examination of human waste sources to determine where gulls are acquiring these elements, and whether or not this can be managed.”

The study, Resistance to critically important antimicrobials in Australian silver gulls (Chroicocephalus novaehollandiae) and evidence of anthropogenic origins, is published in Antimicrobial Chemotherapy.

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
CVS Group hit by cyber attack

CVS Group, which owns more than 450 veterinary practices in the UK, has been hit by a cyber attack.

In a statement, the group said the incident involved unauthorised external access to a limited number of its IT systems. As soon as the attack was discovered, the group took its IT systems temporarily offline, causing 'considerable operational disruption'.

It has warned that the security steps taken and ongoing plans to move its operational systems and IT infrastructure to the Cloud are likely to have an ongoing impact over a number of weeks.

Due to the risk that personal information was accessed, CVS has informed the Information Commissioner's Office. The company is working with third party consultants to investigate the incident.